David Abrams
Abrams Capital Management
Abrams Capital Management 13F holdings
David Abrams's Portfolio
- Portfolio value:
- $4.44B≈
- # of securities:
- 16
- Reported for:
- 31 Mar 2021 (Q1)
- Latest filing date:
- 14 May 2021
What stocks did David Abrams own in 2021 Q1?
What was David Abrams's 2021 Q1 portfolio?
Abrams Capital Management has disclosed a total of 16 security holdings in their (2021 Q1) SEC 13F filing(s) with portfolio value of $4,441,461,000.
Abrams Capital Management's portfolio holdings are tracked quarterly based on SEC 13F filings. Snapshots for each reporting period document the full list of disclosed positions and their portfolio allocations.
David Abrams's original 13F reports (2021 Q1) are the official SEC institutional disclosure documents covering all reported equity positions.
16 results
| History | Ticker | Name |
% of portfolio |
Shares* |
Reported price* |
% difference current price* |
Value | Held since* | Held for* |
Security type |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Lithia Motors Inc
|
20.65%
|
2,351,068
|
$390.09
|
-4.20%($373.71)
|
$917,128,000
|
2018 Q2
|
≈ 3.00 years
|
Common Stock
|
|
|
|
|
|
Asbury Automotive Group Inc
|
9.37%
|
2,118,216
|
$196.50
|
+8.33%($212.86)
|
$416,229,000
|
2017 Q3
|
≈ 3.75 years
|
Common Stock
|
|
|
|
|
|
Meta Platforms Inc
|
7.99%
|
1,205,043
|
$294.53
|
+101.08%($592.25)
|
$354,921,000
|
2018 Q4
|
≈ 2.50 years
|
Common Stock
|
|
|
|
|
|
U-Haul Holding Company
|
7.74%
|
5,612,580
|
$61.26
|
+23.33%($75.55)
|
$343,827,000
|
2016 Q4
|
≈ 4.50 years
|
Common Stock
|
|
|
|
|
|
Transdigm Group Incorporated
|
7.14%
|
539,305
|
$587.92
|
+110.11%($1,235.27)
|
$317,068,000
|
2020 Q1
|
≈ 1.25 years
|
Common Stock
|
|
|
|
|
|
Alphabet Inc, CL-A
|
6.80%
|
2,928,800
|
$103.13
|
+243.90%($354.65)
|
$302,035,000
|
2018 Q2
|
≈ 3.00 years
|
Common Stock
|
|
|
|
|
|
Teva Pharma Industries Ltd ADR
|
6.25%
|
24,046,356
|
$11.54
|
+203.90%($35.07)
|
$277,495,000
|
2017 Q3
|
≈ 3.75 years
|
Depositary Receipt
|
|
|
|
|
|
Change Healthcare Inc
|
6.17%
|
12,400,000
|
$22.10
|
|
$274,040,000
|
2021 Q1
|
≈ 0.25 years
|
Common Stock
|
new
|
+6.17%
|
|
|
|
PG&E Corp
|
6.00%
|
22,745,008
|
$11.71
|
+49.74%($17.54)
|
$266,344,000
|
2019 Q1
|
≈ 2.25 years
|
Common Stock
|
-1.94% (-450K)
|
-0.15%
|
|
|
|
Willis Towers Watson PLC
|
5.64%
|
1,094,001
|
$228.88
|
+50.53%($344.54)
|
$250,395,000
|
2016 Q4
|
≈ 4.50 years
|
Common Stock
|
|
|
|
Completely sold out
4 results
| History | Ticker | Name |
Sold shares* |
% change to portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|
|
|
TransMedics Group Inc
|
-3,499,859
|
-1.96%
|
2019 Q2
|
≈ 1.75 years
|
|
|
|
BRISTOL-MYERS SQUIBB-CVR
|
-24,800,355
|
-0.48%
|
2019 Q4
|
≈ 1.25 years
|
|
|
|
Sculptor Capital Management Inc
|
-521,991
|
-0.22%
|
2016 Q2
|
≈ 4.75 years
|
|
|
|
Clear Channel Outdoor Holdings Inc
|
-3,354,390
|
-0.16%
|
2013 Q2 or earlier
|
≈ 7.75+ years
|
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.